Quipt Home Medical Corp.
Quipt Home Medical Corp. (QIPT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
qipt · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Quipt Home Medical Corp. (QIPT) measures how much investors pay for each dollar of the company's trailing earnings. QIPT's current PE ratio of N/A is calculated by dividing its stock price of $3.65 by its TTM earnings per share of -$0.24.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%2.5x
MedianQ3 · 75%29.8x
Max
At N/A, QIPT's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Quipt Home Medical Corp.You QIPT | $162M | N/A | — | -$0.24 |
 Anebulo Pharmaceuticals, Inc. ANEB | $15M | N/A | — | -$0.25 |
 Apyx Medical Corporation APYX | $200M | N/A | — | -$0.27 |
 Coya Therapeutics, Inc. COYA | $83M | N/A | — | -$1.27 |
 DocGo Inc. DCGO | $54M | N/A | — | -$1.84 |
 FONAR Corporation FONR | $118M | 11.34x | — | $1.32 |
 Hyperfine, Inc. HYPR | $119M | N/A | — | -$0.38 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-0.25 | — | |
2024-09-30 FY2024 | — | $-0.16 | — | |
2023-09-30 FY2023 | — | $-0.07 | — | |
2022-09-30 FY2022 | 29.79x | $0.14 | — | |
2021-09-30 FY2021 | — | $-0.20 | — | |
2020-09-30 FY2020 | — | $-0.22 | — | |
2019-09-30 FY2019 | — | $-0.27 | — | |
2018-09-30 FY2018 | 4.64x | $0.72 | — | |
2017-09-30 FY2017 | — | $-1.02 | — | |
2016-09-30 FY2016 | — | $-3.23 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Quipt Home Medical Corp. (QIPT) measures how much investors pay for each dollar of the company's trailing earnings. QIPT's current PE ratio of N/A is calculated by dividing its stock price of $3.65 by its TTM earnings per share of -$0.24.
Frequently asked questions
QIPT pe ratio · 6 questionsQIPT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $3.65 and TTM EPS of -$0.24. Data sourced from Financial Modeling Prep via QIPT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Quipt Home Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09